These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 23533010)

  • 1. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
    Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.
    Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P
    Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of lacosamide in the intensive care unit.
    Cherry S; Judd L; Muniz JC; Elzawahry H; LaRoche S
    Neurocrit Care; 2012 Apr; 16(2):294-8. PubMed ID: 22203547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study.
    Hottinger A; Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2012 Sep; 26(9):761-72. PubMed ID: 22823481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population.
    d'Orsi G; Pascarella MG; Martino T; Carapelle E; Pacillo F; Di Claudio MT; Mancini D; Trivisano M; Avolio C; Specchio LM
    Seizure; 2016 Nov; 42():20-28. PubMed ID: 27693808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous lacosamide in refractory seizure clusters and status epilepticus: comparison of 200 and 400 mg loading doses.
    Legros B; Depondt C; Levy-Nogueira M; Ligot N; Mavroudakis N; Naeije G; Gaspard N
    Neurocrit Care; 2014 Jun; 20(3):484-8. PubMed ID: 23896816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of lacosamide versus sodium valproate in status epilepticus: A pilot study.
    Misra UK; Dubey D; Kalita J
    Epilepsy Behav; 2017 Nov; 76():110-113. PubMed ID: 28919386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus.
    Moreno Morales EY; Fernandez Peleteiro M; Bondy Peña EC; Domínguez Lorenzo JM; Pardellas Santiago E; Fernández A
    Clin Drug Investig; 2015 Jul; 35(7):463-9. PubMed ID: 26108190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Safety and Effectiveness of Intravenous Lacosamide for Refractory Status Epilepticus in the Critically Ill.
    Newey CR; Le NM; Ahrens C; Sahota P; Hantus S
    Neurocrit Care; 2017 Apr; 26(2):273-279. PubMed ID: 27844464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
    Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
    Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Lacosamide in refractory nonconvulsive status epilepticus.
    Mnatsakanyan L; Chung JM; Tsimerinov EI; Eliashiv DS
    Seizure; 2012 Apr; 21(3):198-201. PubMed ID: 22244046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
    Dubey D; Bhoi SK; Kalita J; Misra UK
    Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of intravenous lacosamide in status epilepticus.
    Santamarina E; Toledo M; Sueiras M; Raspall M; Ailouti N; Lainez E; Porta I; De Gracia R; Quintana M; Alvarez-Sabín J; Xavier Salas Puig XS
    J Neurol; 2013 Dec; 260(12):3122-8. PubMed ID: 24122063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacosamide as adjunctive therapy in refractory epilepsy in adults: a systematic review.
    Paquette V; Culley C; Greanya ED; Ensom MH
    Seizure; 2015 Feb; 25():1-17. PubMed ID: 25645629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy.
    Santamarina E; González-Cuevas M; Toledo M; Jiménez M; Becerra JL; Quílez A; Suller A; Mauri JA; Fernández Á; Marinas A; Quintana M; Puig XS
    Epilepsy Behav; 2018 Jul; 84():93-98. PubMed ID: 29758445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study.
    Miró J; Toledo M; Santamarina E; Ricciardi AC; Villanueva V; Pato A; Ruiz J; Juvany R; Falip M
    Seizure; 2013 Jan; 22(1):77-9. PubMed ID: 23127776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of lacosamide in refractory status epilepticus.
    Goodwin H; Hinson HE; Shermock KM; Karanjia N; Lewin JJ
    Neurocrit Care; 2011 Jun; 14(3):348-53. PubMed ID: 21249530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose oral lacosamide in refractory simple partial status epilepticus: case report and review.
    Hawkes MA; Fernández Suárez M; Ugarnes G; D'Giano C
    Clin Neuropharmacol; 2013; 36(4):138-40. PubMed ID: 23860347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perampanel Treatment for Refractory Status Epilepticus in a Neurological Intensive Care Unit.
    Ho CJ; Lin CH; Lu YT; Shih FY; Hsu CW; Tsai WC; Tsai MH
    Neurocrit Care; 2019 Aug; 31(1):24-29. PubMed ID: 30891695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.